The CLL Society Medical & Scientific Advisory Board is comprised of distinguished physician-scientist researchers who specialize in CLL as well as respected doctors who treat a significant number of CLL patients in their practice. The board advises the CLL Society on the latest research in CLL and advances in medical treatment, as well as issues related to patient care.
John Byrd, MD
D Warren Brown Chair of Leukemia Research
Director, Division of Hematology
The Ohio State Comprehensive Cancer Center
Columbus, OH
Richard Furman, MD
Director of the CLL Research Center
Member of the Lymphoma/Myeloma Service
Division of Hematology/Oncology
Weill Cornell Medical College
New York, NY
Thomas E Henry III, MBA, RPh, CPh
Chief Pharmacy Officer
Moffitt Cancer Center
Tampa, FL
Kaitlin Kennard, BSN, RN
CLL Program Nurse
Center for Chronic Lymphocytic Leukemia
Abramson Cancer Center of the University of Pennsylvania
Philadelphia, PA
Thomas Kipps, MD, PhD
Professor of Medicine
Division of Hematology-Oncology
Deputy Director of Research
University of California, San Diego Moores Cancer Center
La Jolla, CA
Anthony Mato, MD, MSCE
Director, CLL Program
Memorial Sloan Kettering Cancer Center
New York, NY
John M. Pagel, MD, PhD
Chief of the Hematologic Malignancy Program and Director of Stem Cell Transplantation
Center for Blood Disorders and Stem Cell Transplantation
Swedish Cancer Institute
Seattle, WA
Steven T Rosen, MD
Provost and Chief Scientific Officer
Director, Comprehensive Cancer Center and Beckman Research Institute
City of Hope
Duarte, CA
Sanjay Sharma, MD
Hemotologist/Oncologist
St. Jude Medical Center
Fullerton, CA
William G. Wierda, MD, PhD
Associate Professor
Clinical Medical Director
Department of Leukemia
The University of Texas MD Anderson Cancer Center
Houston, TX
Leave Comment